Phosphorylation and hypoxia-induced heme oxygenase-1 gene expression in cardiomyocytes

Guimei Wu1, José Marín-García, Terry B Rogers

  • 1The Molecular Cardiology and Neuromuscular Institute, 75 Raritan Avenue, Highland Park, NJ 08904, USA.

Journal of Cardiac Failure
|December 16, 2004
PubMed

Insights

Hypoxia increases heme oxygenase-1 (HO-1) expression in cardiomyocytes via protein kinase activation and phosphatase-1 (PP-1) downregulation. Nuclear factors NF-kB and AP-1 are involved in this stress response.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Cellular Stress Response

Background:

  • Heme oxygenase-1 (HO-1) is a key stress protein regulating heme degradation.
  • Cardiomyocytes respond to hypoxic stress through complex molecular pathways.
  • The role of protein phosphorylation and dephosphorylation in HO-1 regulation under hypoxia was investigated.

Purpose of the Study:

  • To investigate the role of protein kinases and phosphatases in modulating HO-1 expression in cardiomyocytes during hypoxia.
  • To elucidate the signaling pathways involved in hypoxia-induced HO-1 gene expression.

Main Methods:

  • Neonatal rat cardiomyocytes were exposed to hypoxic conditions.
  • HO-1 expression was assessed using Northern blot, Western blot, and transfection assays.
  • Kinase and phosphatase inhibitors (staurosporine, SB202190, okadaic acid) and antisense vectors were employed.

Main Results:

  • Hypoxia significantly induced HO-1 expression in cardiomyocytes.
  • Kinase inhibitors blocked hypoxia-induced HO-1 expression, while phosphatase inhibition (OA, antisense PP-1) induced it.
  • Nuclear factors NF-kB and AP-1 were identified as key players in the HO-1 promoter activation under hypoxia.

Conclusions:

  • Protein kinase activation and reduced phosphatase-1 (PP-1) activity contribute to hypoxia-induced HO-1 gene expression in cardiomyocytes.
  • The HO-1 promoter region, including NF-kB and AP-1 binding sites, is crucial for transcriptional activation during hypoxic stress.
Abstract

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...